Market Cap 8.04M
Revenue (ttm) 0.00
Net Income (ttm) -24.25M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 6,600
Avg Vol 571,580
Day's Range N/A - N/A
Shares Out 5.09M
Stochastic %K 18%
Beta 1.43
Analysts Hold
Price Target $50.00

Company Profile

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is MAT2203, an oral formulation of amphotericin B that is starting Phase 3 clinical trials for the treatment of asp...

Industry: Biotechnology
Sector: Healthcare
Phone: 908 484 8805
Address:
1545 Route 206 South, Suite 302, Bedminster, United States
CloseTheGap
CloseTheGap Oct. 22 at 1:59 AM
$MTNB These guys still pulling a salary? WTF have they been doing the past 6 years
0 · Reply
Daveo460
Daveo460 Oct. 18 at 1:27 AM
$MTNB just checking in, I see that nothing has changed
0 · Reply
Highly_Favored
Highly_Favored Oct. 14 at 2:02 PM
$MTNB only down 91%.
0 · Reply
tdohm22
tdohm22 Oct. 13 at 5:41 PM
$MTNB https://news.exeter.ac.uk/faculty-of-health-and-life-sciences/exeter-boosts-global-fight-against-antifungal-resistance-with-2-8m-funding/ Like what is this f*cking bullsh*t? Hey guys! You don’t need to continue this research. Matinas solved this. Mat2203’tackles all un-met f*cking fungal needs. Including a $2B+ annual market size of c. Auris. WHAT is wrong with everyone in this f*cking space. I’m losing my f*cking mind. I can’t remain illiquid any longer.
1 · Reply
Lacuna_Reborn
Lacuna_Reborn Oct. 10 at 4:38 PM
Cut $STTK and $HUDI for small losses Market ruined technical setups. Still holding $MTNB
0 · Reply
Lacuna_Reborn
Lacuna_Reborn Oct. 8 at 2:48 PM
$MTNB $HUDI My two largest holdings. In early - they'll run soon.
0 · Reply
ForeignInfluence
ForeignInfluence Oct. 7 at 2:18 PM
$MTNB 1st Resistance Point $1.9713.
0 · Reply
Lacuna_Reborn
Lacuna_Reborn Oct. 6 at 6:50 PM
$MTNB added more Low-float biotech gearing up for potential breakout. Lead drug MAT2203: Oral amphotericin B — could revolutionize antifungal treatment if data stays strong. LNC delivery tech: Matinas’ lipid nanocrystal platform could attract partnerships or licensing deals from bigger pharma. Recent funding: $3.3M preferred + warrants secures runway and removes near-term dilution fears. Setup: Tight float + strong chart base around $1.80–$1.90. Above $2.20 = momentum trigger. Catalysts ahead: Clinical updates, shareholder vote, or partnership news. Targets: $3$5 near term, $6$8+ on clinical success or deal. Speculative, but risk/reward looks prime for a biotech swing. #MTNB #biotech #lowfloat #LNCplatform #momentum
1 · Reply
GammaTactician
GammaTactician Oct. 5 at 12:51 PM
$MTNB Biotech speculation. Pre-revenue stage. Chart shows high risk/reward. No pattern recognition.
0 · Reply
GMBREH
GMBREH Sep. 30 at 11:47 AM
$MTNB 👀
0 · Reply
Latest News on MTNB
Matinas BioPharma Receives NYSE Noncompliance Notice

Jan 10, 2025, 5:15 PM EST - 10 months ago

Matinas BioPharma Receives NYSE Noncompliance Notice


Top trending biotech stocks: ANVS, MTNB, AVTX, TPST

Oct 12, 2023, 11:26 AM EDT - 2 years ago

Top trending biotech stocks: ANVS, MTNB, AVTX, TPST

ANVS AVTX TPST


CloseTheGap
CloseTheGap Oct. 22 at 1:59 AM
$MTNB These guys still pulling a salary? WTF have they been doing the past 6 years
0 · Reply
Daveo460
Daveo460 Oct. 18 at 1:27 AM
$MTNB just checking in, I see that nothing has changed
0 · Reply
Highly_Favored
Highly_Favored Oct. 14 at 2:02 PM
$MTNB only down 91%.
0 · Reply
tdohm22
tdohm22 Oct. 13 at 5:41 PM
$MTNB https://news.exeter.ac.uk/faculty-of-health-and-life-sciences/exeter-boosts-global-fight-against-antifungal-resistance-with-2-8m-funding/ Like what is this f*cking bullsh*t? Hey guys! You don’t need to continue this research. Matinas solved this. Mat2203’tackles all un-met f*cking fungal needs. Including a $2B+ annual market size of c. Auris. WHAT is wrong with everyone in this f*cking space. I’m losing my f*cking mind. I can’t remain illiquid any longer.
1 · Reply
Lacuna_Reborn
Lacuna_Reborn Oct. 10 at 4:38 PM
Cut $STTK and $HUDI for small losses Market ruined technical setups. Still holding $MTNB
0 · Reply
Lacuna_Reborn
Lacuna_Reborn Oct. 8 at 2:48 PM
$MTNB $HUDI My two largest holdings. In early - they'll run soon.
0 · Reply
ForeignInfluence
ForeignInfluence Oct. 7 at 2:18 PM
$MTNB 1st Resistance Point $1.9713.
0 · Reply
Lacuna_Reborn
Lacuna_Reborn Oct. 6 at 6:50 PM
$MTNB added more Low-float biotech gearing up for potential breakout. Lead drug MAT2203: Oral amphotericin B — could revolutionize antifungal treatment if data stays strong. LNC delivery tech: Matinas’ lipid nanocrystal platform could attract partnerships or licensing deals from bigger pharma. Recent funding: $3.3M preferred + warrants secures runway and removes near-term dilution fears. Setup: Tight float + strong chart base around $1.80–$1.90. Above $2.20 = momentum trigger. Catalysts ahead: Clinical updates, shareholder vote, or partnership news. Targets: $3$5 near term, $6$8+ on clinical success or deal. Speculative, but risk/reward looks prime for a biotech swing. #MTNB #biotech #lowfloat #LNCplatform #momentum
1 · Reply
GammaTactician
GammaTactician Oct. 5 at 12:51 PM
$MTNB Biotech speculation. Pre-revenue stage. Chart shows high risk/reward. No pattern recognition.
0 · Reply
GMBREH
GMBREH Sep. 30 at 11:47 AM
$MTNB 👀
0 · Reply
Kevin73ca
Kevin73ca Sep. 26 at 11:52 AM
$GPUS Keep eyes on $MTNB I took position yesterday after market at 1.83
0 · Reply
Kevin73ca
Kevin73ca Sep. 25 at 9:50 PM
$MRM $MTNB Some one knows how to get cheap shares I got in 1.83 got little qty
0 · Reply
Dieseld28
Dieseld28 Sep. 25 at 9:35 PM
$MTNB Next like $MRM $KUKE
0 · Reply
Dieseld28
Dieseld28 Sep. 25 at 9:29 PM
0 · Reply
Lacuna_Reborn
Lacuna_Reborn Sep. 25 at 8:58 PM
$MTNB new entry $2
0 · Reply
Dieseld28
Dieseld28 Sep. 25 at 8:27 PM
$MTNB https://archive.fast-edgar.com/20250925/AW22T22CLZ22RT4222ZM2ZY27UMOM222E27Q/
0 · Reply
Aagam447
Aagam447 Sep. 25 at 8:25 PM
$MTNB whats the news?
1 · Reply
BigSqueezeComing
BigSqueezeComing Sep. 25 at 8:24 PM
$MTNB AH runners list
0 · Reply
dbr_island
dbr_island Sep. 25 at 8:23 PM
$MTNB there it goes … 🚨ICU🚨 adding as this looks like an overreaction WATCH AND LEARN LIKE HIM👇
0 · Reply
Godwins26
Godwins26 Sep. 25 at 11:32 AM
3rd Watchlist for today $RAYA Bulls are watching this closely today 👀 $SPRC $OFAL $MTNB $WKEY
0 · Reply
ForeignInfluence
ForeignInfluence Sep. 25 at 9:32 AM
$MTNB Resistance remains right at $2.
0 · Reply
HansDampf1
HansDampf1 Sep. 24 at 11:53 AM
$MTNB Matinas BioPharma Holdings, Inc. (MTNB) Restructures Amid Challenges, Focuses on Oral Antifungal MAT2203 https://finance.yahoo.com/news/matinas-biopharma-holdings-inc-mtnb-232217033.html The author prefers KI Cpmpanies
0 · Reply